Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Sunwave Health Revolutionizes Behavioral Health Documentation with MARA, the AI Assistant


DELRAY BEACH, Fla., March 28, 2024 /PRNewswire/ -- Sunwave Health, a leader in healthcare technology, proudly announces the launch of MARA, a patent-pending, innovative AI Agent designed to transform the landscape of behavioral health documentation. Since its launch on October 25, 2023, MARA has already made a significant impact by documenting over 100,000 patient sessions with this groundbreaking technology.

"MARA has revolutionized our documentation and compliance, significantly speeding up the process."

MARA, the Mental-Health Artificial Reasoning Agent, is crafted to revolutionize clinicians' workflow in the behavioral health sector. It streamlines the documentation process, ensuring accuracy and efficiency, allowing clinicians more time to focus on patient care. Lindsey Beezley, Director of Solutions Engineering at Sunwave Health, encapsulates the essence of MARA: "More Time for Patients, Less Time on Notes." This AI Agent is your partner in enhancing therapeutic strategies and outcomes through efficiency and unmatched accuracy.

The MARA Advantage:

Client Testimonial:

Jimmy Campbell, Chief Operating Officer at Freeman Recovery, shares his insights: "MARA has revolutionized our documentation and compliance, significantly speeding up the process and alleviating clinician burden. We're keeping up with our 24-hour deadlines, and it's not overwhelming for our team anymore. Most crucially, it's freed up more time for client care, transforming patient interaction profoundly."

Future Expansion: MARA represents just the beginning of Sunwave Health's ambitious vision. Planned expansions will integrate MARA further into our unified platform, enhancing patient data and operational efficiencies across the board. Diego Soloaga, SVP of Product Management at Sunwave Health, comments, 'The adoption and positive feedback for MARA reaffirm our leading role in mental health innovation. We're excited to keep advancing the field.'

Founder's Insights:

Elie Levy, Founder/CEO of Sunwave Health, introduces MARA as a revolutionary AI agent, stating, "MARA is not just a tool for documenting patient sessions; it's a revolutionary platform that empowers healthcare professionals to provide better, more personalized care."

Sunwave Health invites behavioral health professionals and organizations to join the MARA revolution and experience the transformative capabilities of this cutting-edge Generative AI tool.

Freeman Recovery Corporate Summary:

Located in Dickson, Tennessee, Freeman Recovery specializes in evidence-based treatment for substance use and mental health disorders and is accredited by the Joint Commission. For more information about Freeman Recovery, visit www.freemanrecoverycenter.com.

Sunwave Health Corporate Summary:

Based in Delray Beach, Florida, Sunwave Health provides innovative healthcare technology solutions, focusing on the behavioral health industry. For more information about MARA and Sunwave Health, visit www.sunwavehealth.com/

SOURCE Sunwave Health


These press releases may also interest you

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...



News published on and distributed by: